Perrigo Sets Generic Mucinex Launch After Patent Claim Decision
This article was originally published in The Tan Sheet
The private labeler clears a Reckitt Benckiser legal hurdle and will launch generic Mucinex (guaifenesin) by April. Watson has filed ANDAs for three Mucinex products and could be a good strategic partner for Perrigo, an analyst suggests.
You may also be interested in...
MiraLAX, Zegerid lead Merck OTCs
Perrigo stokes momentum behind already healthy sales growth with significant steps in separate areas: a green light for regulatory compliance at its main manufacturing plant, and the launch of its generic OTC versions of Sanofi-Aventis' Allegra.
Watson to push FDA on Mucinex ANDAs